HOME >> MEDICINE >> NEWS
U.S., British scientific societies honor penicillin as International Chemical Landmark

The development of penicillin, one of the 20th century's greatest lifesavers, will be honored as an International Historic Chemical Landmark at 11a.m. Friday, Nov. 19 in London. The designation takes place 70 years after the discovery of the drug was first published by Alexander Fleming.

Representatives from the government, academic and private sector research teams that helped move Fleming's discovery from the lab to the hospital will be reunited in London for the designation of the landmark by the Royal Society of Chemistry and the Washington, D.C.-based American Chemical Society. The last surviving member of the original research team, biochemist Norman Heatley of Oxford University, will be a special guest at the ceremony, to be held at Fleming's laboratory in St. Mary's Hospital, London.

While Fleming's identification of penicillin and its potential uses was first published in 1929, development of a viable drug and the ability to mass-produce it during World War II proved tougher obstacles to surmount. Researchers from Oxford University in England were able to test penicillin in mice and in humans, then sought wartime help in funding, further research, and manufacturing from U.S. government agencies, academic institutions and pharmaceutical company labs. The resulting teamwork was carried forward when, after the U.S. entry into World War II, the government recruited more than 20 chemical companies to mass-produce the drug. The result: Deaths from infected wounds during the war were virtually eliminated, as 95 percent of the wounded soldiers survived.

The American Chemical Society designates important steps in the evolution of chemical science and technology as Historic Chemical Landmarks. "The landmarks program reminds us of the grandeur of chemistry, while underlining that chemistry is a very human enterprise, filled with all triumphs and setbacks of men and women trying to understand the world and make it better," said Ed Wasserman,
'"/>

Contact: Kathleen Milanich
k_milanich
202-872-4493
American Chemical Society
14-Nov-1999


Page: 1 2

Related medicine news :

1. Sepsis on the increase in U.S., according to Emory University and CDC study
2. U.S., Mexican scientific societies honor former Penn State professor
3. British hospitals need clinical ethicists
4. Concerns over the future of childrens health care in British general practice
5. British conservatives should beware of Australian health service reforms
6. Heart disease risk in British men is overestimated
7. US women endure twice the surgical biopsies as British for same cancer detection rate
8. British scientists receive Lasker Prize for discovering new treatment for rheumatoid arthritis
9. British public supports mercy killing
10. British Adolescents Need Government Support To Help Clean Up Their Act
11. Public morally obliged to take part in scientific research, says leading ethicist

Post Your Comments:
(Date:7/31/2014)... David Kekich, anti-aging icon and CEO of ... that the acceptance of his revolutionary approach of ... algorithms and then screening thousands of compounds against ... , “It took longer than I thought and ... said Kekich. "Client acceptance is exploding, early clinical ...
(Date:7/31/2014)... Malaysia (PRWEB) July 31, 2014 ... mymobileuni.com, entered into strategic alliance with Dr. Lawrence ... and provide content to http://www.mymobileuni.com its ... Channel http://www.mymobileuni.net/mu3/health.php will include courses, e-books ... who want to learn, re-skill or up-skill themselves ...
(Date:7/31/2014)... 2014 (HealthDay News) -- The virus that causes cold sores ... the absence of symptoms, according to a new study. ... the cells of people infected with the virus. This explains ... and why others get them only occasionally. The authors said ... "We thought when the disease was dormant, it ...
(Date:7/31/2014)... MO (PRWEB) July 31, 2014 Saint ... with an Excellence Through Insight award for Overall Patient ... and Systems (CG-CAHPS) database in multiple categories by HealthStream, ... their commitment to excellence in patient care. To qualify ... been a patient satisfaction-tracking client of HealthStream in 2013, ...
(Date:7/31/2014)... OK (PRWEB) July 31, 2014 Shiitakes ... As in the recipe for Quick-Fix Spaghetti Sauce below, ... second-most consumed mushroom worldwide, valued for their deep flavor ... mushrooms. They absorb flavors of the foods they're cooked ... texture and offer high-protein, low-fat nutrition. Shiitakes are rich ...
Breaking Medicine News(10 mins):Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:MyMobileUniversity and Fortech International Form Strategic Alliance That Will Enhance the Global Health and Medical Channel on Its Website 2Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3
(Date:7/31/2014)... July 31, 2014 Touro University California,s College ... selected as the recipient of a $150,000 grant by ... the University to increase research and classroom space on ... technology for the study of health sciences, and will ... needs and interests of our students," said Shelley ...
(Date:7/31/2014)... , July 31, 2014 Hovione today ... has successfully passed a pre-approval inspection by the ... carried out by the FDA Consumer Safety Officer, Ms. ... on 21 st July and concluded on the 25 ... with the principles and guidelines of Good Manufacturing Practices (GMP) ...
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2
Cached News: